Newsroom Stories

A grant to WashU Medicine researchers will fund the study of how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia.

WashU plant scientist Ben Mansfeld is studying the genome of wild crabapples to find helpful traits to develop in domestic apple varieties.

With the advent of Google AI Overviews, Google has unprecedented editorial control over what users read and know, according to Jacob Montgomery, a WashU Arts & Sciences political scientist.

In a mouse study, WashU Medicine researchers show that a drug injected into the body can reduce damage caused by a protein called tau, which accumulates in the brain in Alzheimer’s and related neurological diseases.

A study led by WashU Medicine researchers found that near-daily cannabis users with drug-resistant epilepsy had over twice as many convulsive seizures as nonusers, and they became resistant to antiseizure medications faster.

Biomedical engineers at WashU McKelvey Engineering developed an additive manufacturing method using a 3D printer that builds bioelectronic materials from collagen and a polymer that can carry electrical signals, work that could ultimately improve the function of medical implants.

Adults with a history of cancer are less likely to be physically active than those without a cancer history, finds a new study from Washington University in St. Louis.

About 400 WashU students turned out for “What’s Your Summer Scoop?”, hosted by the Center for Career Engagement. Students shared information about their internships, fellowships, research experiences, summer jobs and volunteer service. The center will use that information to provide experiential learning resources.

WashU Medicine researchers found that dozens of blood proteins shifted during treatment with the anti-amyloid medication lecanemab, which could enable future blood tests monitoring a person’s response to the drug.

WashU Medicine allergist and immunologist Maya Jerath, MD, PhD, has treated over 650 patients with alpha-gal, a potentially life-threatening allergic reaction triggered by tick bites — and the prevalence is increasing rapidly, she says.